Notices to Creditors
MACROPHAGE PHARMA LIMITED
(Company Number 09369013)
Research and experimental development on biotechnology
Previous Name of Company: Macrophage Therapeutics Limited (29 December 2014 – 27 February 2015)
Registered office: C/O Cork Gully LLP, 6 Snow Hill, London, EC1A 2AY
Notice is hereby given that the Creditors of the above named Company are required, on or before 10 March 2023, to prove their debts by delivering their proofs (in the format specified in Rule 14.4 of the Insolvency (England and Wales) Rules 2016) to the Joint Liquidators at Cork Gully LLP, 6 Snow Hill, London, EC1A 2AY or alternatively to darrenhabgood@corkgully.com.
If so required by notice from the Liquidator, creditors must produce any document or other evidence which the Liquidator considers is necessary to substantiate the whole or any part of a claim.
Date of Appointment: 16 February 2023
Office Holder Details: Stephen Robert Cork (IP No. 8672) and Anthony Malcolm Cork (IP No. 009401) both of Cork Gully LLP, 6 Snow Hill, London, EC1A 2AY
Further details contact: The Joint Liquidators, Tel: 0207 268 2150. Alternative contact: Darren Habgood Email: darrenhabgood@corkgully.com
Stephen Robert Cork, Joint Liquidator
1 March 2023
Ag AJ120038
